Latest Regulatory Approvals News

Emyria Limited is scaling up its Perth Empax clinic with increased therapist approvals and treatment rooms, setting the stage for broader national clinical growth next year.

Beetaloo Energy has reached a Final Investment Decision for its Carpentaria Pilot Project, paving the way for gas sales from EP187 starting in 2026. This milestone follows key agreements and approvals, marking a significant step in Northern Territory’s energy development.

Bioxyne Limited has secured a pioneering manufacturing and supply agreement to enter the emerging medicinal cannabis markets of Costa Rica and Panama, positioning itself as a first mover with promising revenue potential.

Native Mineral Resources reports steady gold production at Blackjack with 1,300 ounces yielded and $7.6 million revenue, while advancing regulatory and joint venture developments.

Jameson Resources has raised an extra A$450,000 through a discounted share placement, reinforcing investor confidence in its Crown Mountain coal project amid ongoing regulatory progress.

Lunnon Metals reports significant high-grade gold assay results from the Lady Herial deposit, confirming promising mineralisation below and within the planned open pit. The company advances towards regulatory approvals and a final investment decision.

St Barbara Limited has locked in A$470 million in funding through strategic partnerships with Lingbao Gold Group and Kumul Mineral Holdings, fully financing the Simberi Gold Project expansion and accelerating its development timeline.

St Barbara Limited has agreed to sell a 20% interest in its Simberi Gold Project to Papua New Guinea’s Kumul Mineral Holdings for A$100 million, forming a strategic joint venture that aligns with PNG’s resource ownership goals.

St Barbara Limited’s latest Feasibility Study confirms the Simberi Expansion Project as a long-life, low-cost gold and silver operation with robust economics and a 13-year mine life. The project promises over 2 million ounces of gold production and competitive costs, pending key regulatory approvals.

Almonty Industries has priced an upsized US$112.5 million share offering to accelerate development of key tungsten and molybdenum projects, reinforcing its position amid tightening global supply chains.

Critical Metals Corp has partnered with Romania's state-owned FPCU in a 50/50 joint venture, securing half of the Tanbreez rare earth concentrate and boosting European supply chain security.

Mayne Pharma has rejected Cosette Pharmaceuticals’ notice to terminate their merger agreement, citing Cosette’s failure to meet obligations that led to regulatory approval issues. The dispute raises fresh uncertainty over the proposed acquisition’s future.